IL101241A
(en)
*
|
1992-03-16 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
|
DE4244122C1
(de)
*
|
1992-12-24 |
1994-06-01 |
Sanol Arznei Schwarz Gmbh |
Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
|
ATE223231T1
(de)
*
|
1993-04-19 |
2002-09-15 |
Inst Advanced Skin Res Inc |
Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5576016A
(en)
*
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
IL106578A
(en)
*
|
1993-08-03 |
2000-08-13 |
Yissum Res Dev Co |
Pharmaceutical compositions for drug targeting
|
FR2709666B1
(fr)
*
|
1993-09-07 |
1995-10-13 |
Oreal |
Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
US5672358A
(en)
*
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
JPH0827018A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sanwa Kagaku Kenkyusho Co Ltd |
生理活性ペプチド又は蛋白質を含有する薬剤組成物
|
CN1211192A
(zh)
*
|
1995-09-18 |
1999-03-17 |
美国陆军医疗材料研究指挥部 |
生产非共价复合的多价蛋白体亚基疫苗的改进方法
|
WO1997015306A1
(en)
*
|
1995-10-25 |
1997-05-01 |
Janssen Pharmaceutica N.V. |
Infusions of neuroprotectants and perfluorochemicals
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
ES2118033B1
(es)
*
|
1996-02-16 |
1999-07-01 |
Bial Ind Farmaceutica S A |
Formulacion farmaceutica antiinflamatoria.
|
SE9602280D0
(sv)
*
|
1996-06-10 |
1996-06-10 |
Pharmatrix Ab |
Immunstimulerande lipidformulering
|
AU727447B2
(en)
*
|
1996-07-03 |
2000-12-14 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
PL192560B1
(pl)
*
|
1996-08-22 |
2006-11-30 |
Res Triangle Pharm Ltd |
Sposób zmniejszania wielkości mikrocząstek i kompozycja zawierająca mikrocząstki
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
SE9603667D0
(sv)
*
|
1996-10-08 |
1996-10-08 |
Astra Ab |
Pharmaceutical compositions
|
US6071904A
(en)
*
|
1996-12-11 |
2000-06-06 |
Alcon Laboratories, Inc. |
Process for manufacturing ophthalmic suspensions
|
US7060277B2
(en)
*
|
1996-12-30 |
2006-06-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins
|
US6537561B1
(en)
*
|
1997-02-27 |
2003-03-25 |
Nippon Shinyaku Co., Ltd. |
Fat emulsion for oral administration
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US5980912A
(en)
*
|
1997-03-25 |
1999-11-09 |
Zonagen, Inc. |
Chitosan induced immunopotentiation
|
SE9702776D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Pharmacia & Upjohn Ab |
Method of preparing pharmaceutical compositions
|
US6306433B1
(en)
|
1997-08-12 |
2001-10-23 |
Pharmacia Ab |
Method of preparing pharmaceutical compositions
|
IL122084A
(en)
*
|
1997-10-31 |
1999-09-22 |
Lurident Ltd |
Formulation for personal care with mucoadhesive properties
|
US6270464B1
(en)
|
1998-06-22 |
2001-08-07 |
Artemis Medical, Inc. |
Biopsy localization method and device
|
GB9726916D0
(en)
*
|
1997-12-19 |
1998-02-18 |
Danbiosyst Uk |
Nasal formulation
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US6017545A
(en)
*
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
DE69923300T2
(de)
|
1998-03-09 |
2006-01-05 |
Takeda Pharmaceutical Co. Ltd. |
Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
|
DE19819273A1
(de)
*
|
1998-04-30 |
1999-11-11 |
Pharmatec International S Giul |
Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
|
JP2002513773A
(ja)
*
|
1998-05-07 |
2002-05-14 |
コリクサ コーポレイション |
アジュバント組成物及びその使用法
|
TWI241915B
(en)
|
1998-05-11 |
2005-10-21 |
Ciba Sc Holding Ag |
A method of preparing a pharmaceutical end formulation using a nanodispersion
|
CA2333648C
(en)
|
1998-05-29 |
2008-10-21 |
Rtp Pharma Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
EP1091762A1
(de)
*
|
1998-07-02 |
2001-04-18 |
Genzyme Corporation |
Expression von transgenen in polarisierten zellen
|
DE19830375A1
(de)
*
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
JP2007262088A
(ja)
*
|
1998-08-31 |
2007-10-11 |
Nipro Corp |
栄養輸液製剤
|
DE69929128T2
(de)
*
|
1998-08-31 |
2006-06-29 |
Nipro Corp. |
Nährstoffinfusionspräparat
|
AU6333499A
(en)
*
|
1998-10-14 |
2000-05-01 |
Cognis Deutschland Gmbh |
Use of nanoscale sterols and sterol esters
|
CN1287769C
(zh)
|
1998-11-20 |
2006-12-06 |
斯凯伊药品加拿大公司 |
可分散的磷脂稳定的微粒
|
FR2787326B1
(fr)
*
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
NZ512599A
(en)
*
|
1998-12-30 |
2003-10-31 |
Dexcel Ltd |
Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
|
US7655252B2
(en)
*
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US8236335B2
(en)
*
|
1999-04-28 |
2012-08-07 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US7767216B2
(en)
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
WO2000067728A2
(de)
*
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
|
EP1189597A4
(de)
*
|
1999-06-04 |
2008-06-18 |
Pacira Pharmaceuticals Inc |
Zusammensetzungen mit einem öl-kern zur verzögerten freisetzung hydrophober arzneistoffe
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US7919113B2
(en)
*
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
US6541025B1
(en)
|
1999-12-30 |
2003-04-01 |
Shear/Kershman Laboratories, Inc. |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
US6514523B1
(en)
|
2000-02-14 |
2003-02-04 |
Ottawa Heart Institute Research Corporation |
Carrier particles for drug delivery and process for preparation
|
US6743900B2
(en)
|
2000-02-15 |
2004-06-01 |
Id Biomedical Corporation Of Quebec |
Proteosome influenza vaccine
|
FR2805761B1
(fr)
*
|
2000-03-02 |
2002-08-30 |
Mainelab |
Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
|
WO2001066700A1
(en)
*
|
2000-03-09 |
2001-09-13 |
Emory University |
Transcutaneous immunization for large particulate antigens
|
US6861060B1
(en)
|
2000-04-21 |
2005-03-01 |
Elena Luriya |
Personal care formulations
|
DE10027948A1
(de)
*
|
2000-06-08 |
2001-12-20 |
Henkel Kgaa |
Verfahren zur Herstellung von Nanopartikel-Suspensionen
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6607784B2
(en)
*
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
EP1528937B1
(de)
*
|
2001-06-05 |
2016-08-10 |
The Regents Of The University Of Michigan |
Nanoemulsionsvakzine
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
CN102294023A
(zh)
*
|
2001-07-26 |
2011-12-28 |
奥塔戈创新公司 |
抗原组合物
|
JP5137289B2
(ja)
*
|
2001-08-03 |
2013-02-06 |
武田薬品工業株式会社 |
安定な乳化組成物
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
EP1429749A2
(de)
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Herstellung von nanopartikeln im submikrometerbereich durch dispersion und entzug des lösungsmittels oder der flüssigen phase
|
IL145926A0
(en)
*
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
JP4549625B2
(ja)
*
|
2002-01-05 |
2010-09-22 |
株式會社アモーレパシフィック |
人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US6899890B2
(en)
*
|
2002-03-20 |
2005-05-31 |
Kv Pharmaceutical Company |
Bioadhesive drug delivery system
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
US8435942B2
(en)
*
|
2002-05-31 |
2013-05-07 |
Transdermal Biotechnology, Inc. |
Methods for formulating stabilized insulin compositions
|
US20040018237A1
(en)
*
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
HUP0202032A2
(hu)
*
|
2002-06-19 |
2004-10-28 |
D. Endre Radics |
Nanoemulziós formulációban található bioaktív anyagok emberi szervezetbe való bevitele a szájüreg nyálkahártyáján keresztül, mechanikus pumpájú spray által.
|
AU2003257285A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Micrologix Biotech Inc. |
Inhibitors of rna dependent rna polymerase and uses thereof
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
AU2003284304B8
(en)
*
|
2002-10-21 |
2009-08-06 |
Nagler, Richard |
Surface coating comprising bioactive compound
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
KR101108439B1
(ko)
|
2002-10-25 |
2012-01-31 |
포믹스 리미티드 |
화장료 및 약제용 거품제
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
ITMI20022323A1
(it)
*
|
2002-10-31 |
2004-05-01 |
Maria Rosa Gasco |
Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
|
US7255867B2
(en)
*
|
2002-11-15 |
2007-08-14 |
Id Biomedical Corporation Of Quebec |
Vaccine
|
CA2515892C
(en)
|
2003-02-14 |
2012-10-23 |
Children's Hospital & Research Center At Oakland |
Lipophilic drug delivery vehicle and methods of use thereof
|
WO2004084859A2
(en)
*
|
2003-03-21 |
2004-10-07 |
Nastech Pharmaceutical Company Inc. |
Nasal calcitonin formulations containing chlorobutanol
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
US7368537B2
(en)
*
|
2003-07-15 |
2008-05-06 |
Id Biomedical Corporation Of Quebec |
Subunit vaccine against respiratory syncytial virus infection
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US20050152919A1
(en)
*
|
2003-09-15 |
2005-07-14 |
Id Biomedical Corporation Of Quebec |
Measles subunit vaccine
|
WO2005030172A1
(en)
*
|
2003-09-24 |
2005-04-07 |
The Regents Of The University And Methods |
Antimicrobial nanoemulsion compositions and methods
|
CA2541445A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Teva Pharmaceutical Industries Ltd. |
Nanoparticles for drug delivery
|
US20050196416A1
(en)
*
|
2004-02-05 |
2005-09-08 |
Kipp James E. |
Dispersions prepared by use of self-stabilizing agents
|
CA2563544A1
(en)
*
|
2004-04-19 |
2005-10-27 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Lung surfactant supplements
|
ITMI20041151A1
(it)
*
|
2004-06-09 |
2004-09-09 |
Maria Rosa Gasco |
Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
|
US7348802B2
(en)
*
|
2004-06-15 |
2008-03-25 |
Stmicroelectronics Pvt. Ltd. |
Differential receiver
|
KR101347105B1
(ko)
|
2004-06-25 |
2014-01-02 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
신경계 장애의 예방을 위한 조성물 및 방법
|
WO2006068663A2
(en)
*
|
2004-06-30 |
2006-06-29 |
Id Biomedical Corporation Of Quebec |
Vaccine compositions for treating coronavirus infection
|
US7871632B2
(en)
|
2004-07-12 |
2011-01-18 |
Adventrx Pharmaceuticals, Inc. |
Compositions for delivering highly water soluble drugs
|
US20060057216A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Salamone Joseph C |
Low-obscuration image transmitting particulate ocular therapeutic formulations
|
EP1674085A1
(de)
*
|
2004-12-22 |
2006-06-28 |
Universite Libre De Bruxelles |
Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
|
CA2600054A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Combe Incorporated |
Stable mixed emulsions
|
FR2885538B1
(fr)
*
|
2005-05-16 |
2007-08-10 |
Univ Claude Bernard Lyon |
Nouveau procede de preparation de particules lipidiques solides, mettant en oeuvre un reacteur membranaire
|
FR2887457B1
(fr)
*
|
2005-06-23 |
2007-10-05 |
Fond Bettencourt Schueller |
Vaccination par ciblage transcutane
|
JP5368793B2
(ja)
|
2005-07-18 |
2013-12-18 |
ユニバーシティ オブ マサチューセッツ ロウエル |
ナノエマルジョンを製造および使用するための組成物および方法
|
US20070065390A1
(en)
*
|
2005-09-19 |
2007-03-22 |
Eric Spengler |
Stable emulsion systems with high salt tolerance
|
CN101325944B
(zh)
*
|
2005-10-11 |
2013-01-16 |
耶路撒冷希伯来大学伊萨姆研究开发公司 |
用于鼻部给药的组合物
|
US7638142B2
(en)
*
|
2005-10-12 |
2009-12-29 |
Vitamin Science, Inc. |
Therapeutic composition for the treatment of dry eye syndrome
|
WO2007054336A1
(de)
*
|
2005-11-10 |
2007-05-18 |
Vortex-Nanofluid Gmbh |
Vorrichtung und verfahren zum herstellen von dispersionen
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
DK3295955T3
(da)
|
2005-12-01 |
2021-07-05 |
Univ Massachusetts Lowell |
Botulinum nanoemulsioner
|
KR100792557B1
(ko)
*
|
2006-04-05 |
2008-01-09 |
한남대학교 산학협력단 |
나노 캡슐화를 이용하여 제조된 지질 핵 및 고분자 쉘구조를 갖는 단백질 약물 전달용 나노 미립구
|
US9839685B2
(en)
*
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
US20080038295A1
(en)
*
|
2006-04-13 |
2008-02-14 |
Regents Of The University Of Michigan |
Compositions and methods for orthopox virus vaccination
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
US20070243137A1
(en)
*
|
2006-04-18 |
2007-10-18 |
Nanoprobes, Inc. |
Cell and sub-cell methods for imaging and therapy
|
PL2061427T3
(pl)
*
|
2006-09-15 |
2011-12-30 |
Echo Pharmaceuticals Bv |
Granulat zawierający substancję farmaceutycznie aktywną i emulgator oraz sposób jego wytwarzania
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
CA2671447A1
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Amphiphilic entity nanoparticles
|
KR20150028308A
(ko)
|
2006-12-01 |
2015-03-13 |
안테리오스, 인코퍼레이티드 |
펩티드 나노입자 및 이의 용도
|
CN101605808A
(zh)
*
|
2007-02-07 |
2009-12-16 |
希格马托制药工业公司 |
人巨细胞病毒(hcmv)的重组抗原
|
AU2008222822A1
(en)
|
2007-03-05 |
2008-09-12 |
Washington University |
Nanoparticle delivery systems for membrane-integrating peptides
|
EP2142216B1
(de)
*
|
2007-03-30 |
2015-04-22 |
Particle Sciences, Inc. |
Partikelformulierungen und ihre verwendungen
|
US8747872B2
(en)
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
WO2008135828A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
CA2688415C
(en)
|
2007-05-31 |
2015-11-10 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
WO2008149192A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
WO2009042114A2
(en)
|
2007-09-21 |
2009-04-02 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
US9439857B2
(en)
|
2007-11-30 |
2016-09-13 |
Foamix Pharmaceuticals Ltd. |
Foam containing benzoyl peroxide
|
EP2240162A4
(de)
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer
|
EP2231169B1
(de)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
US8906855B2
(en)
|
2007-12-22 |
2014-12-09 |
Vivacelle Bio, Inc. |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8618056B2
(en)
|
2007-12-22 |
2013-12-31 |
Cuthbert O. Simpkins |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8063020B2
(en)
|
2007-12-22 |
2011-11-22 |
Simpkins Cuthbert O |
Resuscitation fluid
|
CA2712120A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
US8609733B2
(en)
*
|
2008-05-19 |
2013-12-17 |
Massachusetts Institute Of Technology |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
US8658699B2
(en)
*
|
2008-05-19 |
2014-02-25 |
Massachusetts Institute Of Technology |
Chemical permeation enhancers enhance nerve blockade by toxins
|
WO2009143524A2
(en)
*
|
2008-05-23 |
2009-11-26 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
DE102008045152A1
(de)
*
|
2008-07-09 |
2010-01-14 |
Universität Duisburg-Essen |
Künstliche Sauerstoffträger und ihre Verwendung
|
WO2010009291A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
JP5722782B2
(ja)
*
|
2008-09-26 |
2015-05-27 |
ナノバイオ コーポレーション |
ナノエマルジョン治療用組成物及びその使用方法
|
US8309107B2
(en)
*
|
2008-10-06 |
2012-11-13 |
Banner Pharmacaps, Inc. |
Stable solutions of orlistat for pharmaceutical dosage forms
|
EP2376089B1
(de)
|
2008-11-17 |
2018-03-14 |
The Regents of the University of Michigan |
Krebsvakzine-zusammensetzungen und anwendungsverfahren dafür
|
FR2939699B1
(fr)
|
2008-12-12 |
2011-05-06 |
Univ Angers |
Procede de preparation de nanoparticules lipidiques
|
CA2749698C
(en)
*
|
2009-01-30 |
2017-08-01 |
Cuthbert O. Simpkins |
Resuscitation fluid
|
US8957207B2
(en)
|
2009-03-24 |
2015-02-17 |
Proteus S.A. |
Methods for producing phycotoxins
|
WO2010121082A2
(en)
*
|
2009-04-15 |
2010-10-21 |
Oxygen Biotherapeutics, Inc. |
Emulsions of perfluorocarbons
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
US8668911B2
(en)
*
|
2009-05-14 |
2014-03-11 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
CN101579291B
(zh)
*
|
2009-05-20 |
2011-06-15 |
清华大学 |
一种白藜芦醇磷脂复合物纳米乳液及其制备方法与应用
|
CA2765511C
(en)
*
|
2009-06-16 |
2015-05-12 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
AU2010279384A1
(en)
|
2009-08-05 |
2012-03-01 |
Wake Forest University |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
WO2011064631A1
(en)
|
2009-10-02 |
2011-06-03 |
Foamix Ltd. |
Surfactant-free, water-free, foamable compositions and breakable foams and their uses
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
CN102933200B
(zh)
*
|
2009-12-18 |
2015-11-25 |
莱迪杜德制药公司 |
包含磷脂的单相凝胶组合物
|
FR2956320B1
(fr)
*
|
2010-02-17 |
2013-12-20 |
Commissariat Energie Atomique |
Nanoemulsion pour la delivrance d'au moins deux agents d'interet
|
US20110229516A1
(en)
*
|
2010-03-18 |
2011-09-22 |
The Clorox Company |
Adjuvant phase inversion concentrated nanoemulsion compositions
|
DK2550020T3
(en)
*
|
2010-03-24 |
2015-10-05 |
Medesis Pharma |
REVERSE MICELLE MICROEMULSION, INCLUDING METAL IONS AND USES THEREOF
|
AU2011230619C1
(en)
|
2010-03-25 |
2016-06-23 |
Oregon Health & Science University |
CMV glycoproteins and recombinant vectors
|
TWI540319B
(zh)
|
2010-03-29 |
2016-07-01 |
中央研究院 |
以細胞質譜分析定量細胞所攝入之奈米/微米粒子
|
CN102232932B
(zh)
*
|
2010-04-27 |
2013-06-05 |
重庆莱美药业股份有限公司 |
果胶-阿霉素轭合物的冻干制剂及制备方法
|
US10758630B2
(en)
|
2010-08-13 |
2020-09-01 |
The Johns Hopkins University |
Topical compositions and methods of detection and treatment
|
US8658676B2
(en)
*
|
2010-10-12 |
2014-02-25 |
The Medicines Company |
Clevidipine emulsion formulations containing antimicrobial agents
|
US20140046181A1
(en)
*
|
2011-01-05 |
2014-02-13 |
The Regents Of The University Of California |
Acoustically responsive particles with decreased cavitation threshold
|
CN103547258B
(zh)
|
2011-03-17 |
2017-10-20 |
特兰斯德梅尔生物工艺股份有限公司 |
局部一氧化氮系统及其使用方法
|
LT2691530T
(lt)
|
2011-06-10 |
2018-08-10 |
Oregon Health & Science University |
Cmv glikoproteinai ir rekombinantiniai vektoriai
|
EP2723452A2
(de)
*
|
2011-06-22 |
2014-04-30 |
Vyome Biosciences Pvt Ltd |
Konjugatbasierte antimykotische und antibakterielle prodrugs
|
AU2012216792A1
(en)
|
2011-09-12 |
2013-03-28 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
|
KR101803902B1
(ko)
*
|
2011-09-16 |
2017-12-04 |
(주)아모레퍼시픽 |
세라마이드를 포함하는 피부 외용제 조성물
|
CA2848219A1
(en)
*
|
2011-09-16 |
2013-03-21 |
Nanocare Technologies, Inc. |
Compositions of jasmonate compounds and methods of use
|
EP2586461A1
(de)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Von einem eingehüllten Virus abgeleitete Virenpartikel
|
WO2013082503A1
(en)
*
|
2011-12-01 |
2013-06-06 |
Flow Pharma, Inc. |
Peptide particle formulation
|
EP4218808A3
(de)
|
2012-03-12 |
2023-08-09 |
Advanced BioAdjuvants, LLC |
Adjuvans- und impfstoffzusammensetzungen
|
TWI483747B
(zh)
*
|
2012-05-29 |
2015-05-11 |
Univ Nat Chiao Tung |
口服式藥物載體及其製備方法
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US20140234433A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Nicholas V. Perricone |
Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin
|
US20160000905A1
(en)
|
2013-02-25 |
2016-01-07 |
Particle Sciences, Inc. |
Nanoparticle Delivery of TLR Agonists and Antigens
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
KR20150131330A
(ko)
|
2013-03-15 |
2015-11-24 |
더 칠드런스 메디칼 센터 코포레이션 |
지속성 국소 마취용 네오삭시톡신 조합 제형
|
FR3008900B1
(fr)
*
|
2013-07-25 |
2018-03-30 |
Centre Nat Rech Scient |
Nanoparticules lipidiques multicompartimentees
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
EP2873423B1
(de)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Lösliche hiv-1-hüllglykoproteintrimere
|
WO2015057751A1
(en)
|
2013-10-14 |
2015-04-23 |
Nanosphere Health Sciences, Llc |
Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
|
BR112016009207B1
(pt)
|
2013-10-25 |
2022-11-22 |
Insmed Incorporated |
Compostos de prostaciclina
|
KR20220100041A
(ko)
*
|
2013-12-31 |
2022-07-14 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
단일 바이알 백신 제형
|
US9895311B2
(en)
*
|
2014-09-25 |
2018-02-20 |
Pharmiva Ab |
Foam-forming compositions and methods for delivering an active to a body cavity
|
CA2967385C
(en)
|
2014-11-18 |
2023-05-16 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
US20160151285A1
(en)
*
|
2014-11-28 |
2016-06-02 |
University Of Malaya |
Method to produce slow release delivery carrier lipid nanoparticles of different log p value
|
WO2016100228A2
(en)
|
2014-12-15 |
2016-06-23 |
Nanosphere Health Sciences, Llc |
Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of nsaids
|
JP2018502855A
(ja)
|
2014-12-31 |
2018-02-01 |
ナノケア テクノロジーズ,インコーポレイティド |
ジャスモネート誘導体及びそれらの組成物
|
CA2974208A1
(en)
*
|
2015-01-21 |
2017-04-06 |
Michael WILLINSKY |
Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
|
WO2016144376A1
(en)
*
|
2015-03-10 |
2016-09-15 |
Nanosphere Health Sciences, Llc |
Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
EP3072901A1
(de)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Lösliche hiv-1-hüllglykoproteintrimere
|
US9763892B2
(en)
|
2015-06-01 |
2017-09-19 |
Autotelic Llc |
Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
|
CA3001722A1
(en)
*
|
2015-10-16 |
2017-04-20 |
Marinus Pharmaceuticals, Inc. |
Injectable neurosteroid formulations containing nanoparticles
|
JP2019521979A
(ja)
|
2016-06-13 |
2019-08-08 |
アセンディア ファーマシューティカルズ,エルエルシー |
カルベジロール分散系の非経口徐放送達
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
US11311496B2
(en)
|
2016-11-21 |
2022-04-26 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
WO2018152334A1
(en)
*
|
2017-02-15 |
2018-08-23 |
Molecular Infusions, Llc |
Formulations
|
US11135166B2
(en)
|
2017-05-23 |
2021-10-05 |
Pharmiva Ab |
Foam-forming compositions for delivering an active to a body cavity
|
TWI719263B
(zh)
*
|
2017-10-27 |
2021-02-21 |
財團法人國家衛生研究院 |
用於鼻黏膜之奈米級乳液免疫載劑及其製備方法
|
KR102052912B1
(ko)
*
|
2018-03-30 |
2019-12-06 |
중앙대학교 산학협력단 |
산소를 함유하는 나노 버블의 제조 방법, 나노 버블 및 이를 포함하는 약물 전달체
|
US20200046787A1
(en)
|
2018-07-18 |
2020-02-13 |
Glatt Gmbh |
Extended release formulations of cannabinoids
|
SG11202106144VA
(en)
*
|
2018-12-11 |
2021-07-29 |
Disruption Labs Inc |
Compositions for the delivery of therapeutic agents and methods of use and making thereof
|
WO2020186246A1
(en)
*
|
2019-03-13 |
2020-09-17 |
Ulagaraj Selvaraj |
Stabilized solid nanoparticle formulations of cannabinoids and cannabinoid analogs with reduced ostwald ripening for oral, inhalation, nasal and parenteral drug delivery
|
TR201905678A2
(tr)
*
|
2019-04-16 |
2020-11-23 |
Istanbul Medipol Ueniversitesi |
Kurkumi̇n ve pi̇peri̇n doğal bi̇leşenleri̇ni̇ i̇hti̇va eden kati li̇pi̇t emulsi̇yonlarinin tedavi̇ amaçli uygulamalari
|
CA3138530A1
(en)
|
2019-04-29 |
2020-11-05 |
Insmed Incorporated |
Dry powder compositions of treprostinil prodrugs and methods of use thereof
|
US20200352191A1
(en)
*
|
2019-05-06 |
2020-11-12 |
Karl Lonsbery |
Edible formulations and uses thereof
|
EP4084658A4
(de)
*
|
2020-01-02 |
2024-01-17 |
Spoke Sciences Inc |
Systeme und verfahren zur erzeugung homogener mischungen aus gebrühten getränken und wirkstoffen
|
CA3190642A1
(en)
*
|
2020-07-31 |
2022-02-03 |
Altaire Pharmaceuticals, Inc. |
Ophthalmic compositions for delivering meibum-like materials
|
US11058637B1
(en)
*
|
2020-11-25 |
2021-07-13 |
King Abdulaziz University |
Surface-modified emulsomes for intranasal delivery of drugs
|
WO2023108513A1
(zh)
*
|
2021-12-16 |
2023-06-22 |
威海天原生物科技有限公司 |
植物油制剂及其制备方法
|